Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
An adaptive cellular source of IL-17A and IL-17F is critical for the induction of experimental autoimmune encephalomyelitis.
CAR T-Cell Therapy in Neurology: A Scoping Review of Neuro-Oncology, Autoimmune Diseases & Neurotoxicity.
BCL6 promotes CCR2-driven CNS infiltration of encephalitogenic Th17 cells.
Predicting multiple sclerosis from radiologically isolated syndrome using generative artificial intelligence.
Effects of thoracic manipulation with trigger point therapy on inflammatory cytokine levels in individuals with multiple sclerosis: a pilot study.
Predictors of prognosis in children under six years of age with recurrent croup: a retrospective cohort study.
Medicare Part D Formulary Coverage of Disease-Modifying Therapies for Multiple Sclerosis.
Correction to "Severe Hyponatremia in the Emergency Department. Incidence of Cerebral Edema and Risk of Osmotic Demyelination Syndrome".
Alpha-Lipoic Acid and Biotin in Neurodegenerative Diseases: Convergent Mechanistic Insights from Preclinical Models to Clinical Perspectives.
Navigating the cholesterol maze: Key insights on use of statins in neurodegenerative disorders.
Changes in Regional T1/T2-Weighted Ratio Index in Patients With Semantic Dementia.
Real-World Multicenter Cohort Study of Inebilizumab vs Low-Dose Rituximab in Neuromyelitis Optica Spectrum Disorders.
Understanding late-stage clinical trial failure in multiple sclerosis: insights from ClinicalTrials.gov.
Sex differences in the development, treatment, and prognosis of multiple sclerosis in Switzerland.
Real-World Treatment Adherence and Persistence with C5 Inhibitor Therapy Versus Satralizumab in Patients with Neuromyelitis Optica Spectrum Disorder in Japan.
KDM2B-PP1 Promotes Remyelination and Functional Recovery After Facial Nerve Injury.
Patient profiling in relapsing multiple sclerosis: insights from a real-world observational study into the unmet medical needs of patients on disease-modifying therapy.
Associations of social isolation and loneliness with neurological disorders, psychiatric disorders, brain structures and behavioural phenotypes among UK Biobank participants.
7T magnetic resonance imaging of the human spinal cord in multiple sclerosis: Advances, insights and unmet needs.
Hemifacial spasm: a nodal, stretch-mediated paradigm beyond neurovascular compression.
P2X4 Drives Sex-Specific neuroprotection in autoimmune neuroinflammation.
Occurrence of neuronal dysfunction in mice with virus- or toxic-induced lesions in the central nervous system.
The impact of the COVID-19 pandemic on the incidence and clinical profiles of Guillain-Barré syndrome in Japan.
Neuromyelitis optica spectrum disorder in a patient with neurofibromatosis type 1 mimicking spinal cord infarction.
The impact of cognitive impairments on the quality of life of patients with multiple sclerosis.
Pages
« first
‹ previous
…
813
814
815
816
817
818
819
820
821
…
next ›
last »